CpG methylation of the CYP1B1 promoter region epigenetically regulates CYP1B1 expression during the development of some colorectal cancers, and it is likely that cancers with aberrant CYP1B1 expression might show altered response to procarcinogen metabolism and chemotherapy [195]. The gene discussed is CYP1B1; the disease is cancer.